Cue Biopharma Q3 EPS $(0.31) Up From $(0.62) YoY, Sales $984K Up From $449K YoY

Cue Biopharma (NASDAQ:CUE) reported quarterly losses of $(0.31) per share. This is a 50 percent increase over losses of $(0.62) per share from the same period last year. The company reported $984 thousand in sales this

Benzinga · 11/12/2019 21:01

Cue Biopharma (NASDAQ:CUE) reported quarterly losses of $(0.31) per share. This is a 50 percent increase over losses of $(0.62) per share from the same period last year. The company reported $984 thousand in sales this quarter. This is a 119.15 percent increase over sales of $449 thousand the same period last year.